Medicare ineligible PLHIV in Australia An analysis of new data with recommendations for systemic improvements

October 2019
This NAPWHA report is an analysis drawing together several years’ worth of data from the main pharmaceutical industry suppliers of compassionate access antiretroviral (ARV) therapy in Australia and combines this with, for the first time, data from the State and Territory jurisdictions to produce the most accurate estimate to-date of the number of Medicare ineligible PLHIV in Australia. It comes with recommendations for systemic improvements.

Read the full report here: https://bit.ly/35lQezb